Prognostic and predictive impact of NPM1/FLT3-ITD genotypes as defined by 2017 European LeukemiaNet (ELN) risk categorization from randomized patients with acute myeloid leukemia (AML) treated within the International RATIFY Study (ALLIANCE 10603)
- Citation:
- HemaSphere vol 3 (S1) 81–82
- Meeting Instance:
- EHA 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3235
- Pharmas:
- Novartis
- Grants:
- U10CA180821, U10CA180882, U24CA196171;
- Corr. Author:
- Authors:
- Konstanze Döhner Christian Thiede Nikolaus Jahn Ekaterina Panina Agnes Gambietz Thomas W Prior Guido Marcucci Dan Jones Jürgen Krauter Michael Heuser Francesco Lo Coco Tiziana Ottone Josep Nomdedeu Sumithra J Mandrekar Ben L. Sanford Kristine Laumann Susan M. Geyer Rebecca B. Klisovic Andrew Wei Jorge Sierra Miguel A. Sanz Joseph M. Brandwein T. M. M de Witte Joop H. Jansen Dietger Niederwieser Frederick R. Appelbaum Bruno C Medeiros Martin S. Tallman Richard F. Schlenk Arnold Ganser Hubert Serve Gerhard Ehninger Sergio Amadori Insa Gathmann Axel Benner Celine Pallaud Richard A. Larson Richard M. Stone Hartmut Döhner Clara D. Bloomfield
- Networks:
- Study
- ACOSOG-Z901101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords: